Relapsed Refractory B Cell Aggressive Lymphoma clinical trials

Explore recruiting relapsed refractory b cell aggressive lymphoma clinical trials.

Recruiting relapsed refractory b cell aggressive lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory B Cell Aggressive Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First in human study of the infusion of ARI0003 cells in relapsed/refractory to treatment B-cell aggressive lymphoma

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Relapsed Refractory B Cell Aggressive Lymphoma trials by city

Relapsed Refractory B Cell Aggressive Lymphoma in Toronto Relapsed Refractory B Cell Aggressive Lymphoma in Vancouver Relapsed Refractory B Cell Aggressive Lymphoma in Montreal Relapsed Refractory B Cell Aggressive Lymphoma in Calgary Relapsed Refractory B Cell Aggressive Lymphoma in Edmonton Relapsed Refractory B Cell Aggressive Lymphoma in Ottawa Relapsed Refractory B Cell Aggressive Lymphoma in Winnipeg Relapsed Refractory B Cell Aggressive Lymphoma in Quebec City Relapsed Refractory B Cell Aggressive Lymphoma in Hamilton Relapsed Refractory B Cell Aggressive Lymphoma in Kitchener Relapsed Refractory B Cell Aggressive Lymphoma in London Relapsed Refractory B Cell Aggressive Lymphoma in Halifax Relapsed Refractory B Cell Aggressive Lymphoma in New York Relapsed Refractory B Cell Aggressive Lymphoma in Los Angeles Relapsed Refractory B Cell Aggressive Lymphoma in Chicago Relapsed Refractory B Cell Aggressive Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease